Agitated filter-dryers (AFDs) are
commonly used for performing
both filtration and drying operations in the manufacture of active
pharmaceutical ingredients (APIs) and intermediates. Successful scale-up
from the laboratory to manufacturing AFD equipment requires that physical
properties specifications such as particle size be consistently met
in addition to chemical purity specifications. Depending on the API–solvent
system and equipment operational parameters, undesired attrition or
agglomeration may occur, so an improved understanding of these phenomena
upon scale-up is of key importance. In this paper, we describe recent
advances in laboratory methods, based on material characterization
methods common to drug product formulation development, to better
assess the risk of agglomeration and attrition potential upon scale-up.
These methods provide data to evaluate solid behavior, in both wet
and dry states, associated with processing in an AFD. For agglomeration
prediction, the application of mixer torque rheometry for measuring
the propensity to form granules or agglomerates of API wet cake is
described as well as how to categorize agglomeration risk based on
the output of this testing. For measuring attrition propensity, the
application of powder rheometry is described, and risk categories
are proposed. For both testing methods, good agreement was seen between
laboratory predictions and actual behavior upon scale-up. For compounds
evaluated as high risk for attrition or agglomeration, alternate drying
protocols are recommended to mitigate risk. In addition, progress
on enhancing cycle times for difficult to dry materials is discussed.